11-65921411-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006442.4(DRAP1):āc.594G>Cā(p.Glu198Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,609,614 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006442.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DRAP1 | NM_006442.4 | c.594G>C | p.Glu198Asp | missense_variant | 7/7 | ENST00000312515.7 | NP_006433.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRAP1 | ENST00000312515.7 | c.594G>C | p.Glu198Asp | missense_variant | 7/7 | 1 | NM_006442.4 | ENSP00000307850.2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250588Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135420
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1457298Hom.: 0 Cov.: 30 AF XY: 0.00000414 AC XY: 3AN XY: 725168
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.594G>C (p.E198D) alteration is located in exon 7 (coding exon 7) of the DRAP1 gene. This alteration results from a G to C substitution at nucleotide position 594, causing the glutamic acid (E) at amino acid position 198 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at